tolloids

Tolloids are a group of extracellular metalloproteinases that belong to the astacin-like family and are characterized by a catalytic domain that requires zinc-binding for activity. The name derives from the Drosophila gene “tolloid” and reflects the evolutionary conservation of the protein’s sequence across many metazoan species. Human homologues include BMP-1 (bone morphogenetic protein‑1), ADAMTS‑2, ADAMTS‑3, ADAMTS‑12, and ADAMTS‑20, with the latter four designated tolloid‑like (TLL) proteins. These enzymes share a common structural motif comprising a propeptide, a catalytic domain, and in many cases additional C‑terminal domains such as CysR, EGF-like repeats, and TS (TSP1) domains that influence substrate specificity and localization.

Physiologically, tolloids regulate extracellular matrix (ECM) remodeling by cleaving procollagens, latent transforming growth factor‑β binding protein (LTBP) complexes, and matricellular proteins such as versican and aggrecan. Their activity releases biologically active growth factors—including members of the transforming growth factor‑β (TGF‑β) superfamily—and modulates the cross‑linking of collagen fibrils, thereby influencing tissue stiffness and healing. In embryogenesis, tolloids control the morphogen gradients of bone morphogenetic proteins (BMPs), essential for proper skeletal patterning and organ development. In adult tissues, they contribute to wound repair, fibrosis, and the maintenance of cartilage integrity.

Genetic studies have linked mutations in tolloid-like genes to congenital disorders such as Ehlers‑Danlos syndrome type VIIB and to skeletal dysplasias. Moreover, altered tolloid expression is implicated in pathological fibrosis, osteoarthritis, and tumor progression. Therapeutic targeting of tolloid activity is under investigation for conditions ranging from scarring to muscle degenerative diseases, where modulation of ECM turnover may restore tissue function.